Rufy4, a protein belonging to the RUN and FYVE domain-containing protein family, participates in various cellular processes such as autophagy and intracellular trafficking. However, its role in osteoclast-mediated bone resorption remains uncertain. In this study, we investigated the expression and role of the gene in osteoclasts using small interfering RNA (siRNA) transfection and gene overexpression systems. Our findings revealed a significant increase in Rufy4 expression during osteoclast differentiation. Silencing enhanced osteoclast differentiation, intracellular cathepsin K levels, and formation of axial protrusive structures but suppressed bone resorption. Conversely, overexpressing wild-type in osteoclasts hindered differentiation while promoting podosome formation and bone resorption. Similarly, overexpression of a variant lacking the RUN domain mimics the effects of knockdown, significantly increasing intracellular cathepsin K levels, promoting osteoclastogenesis, and elongated axial protrusions formation, yet inhibiting bone resorption. These findings indicate that Rufy4 plays a critical role in osteoclast differentiation and bone resorption by regulating the cytoskeletal organization through its RUN domain. Our study provides new insights into the molecular mechanisms governing osteoclast activity and underscores Rufy4's potential as a novel therapeutic target for bone disorders characterized by excessive bone resorption.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11545195PMC
http://dx.doi.org/10.3390/cells13211766DOI Listing

Publication Analysis

Top Keywords

bone resorption
28
osteoclast differentiation
12
bone
8
cytoskeletal organization
8
organization domain
8
intracellular cathepsin
8
cathepsin levels
8
resorption
7
autophagy regulator
4
regulator rufy
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!